Related Experiment Video
Updated: Aug 16, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
[Patent foramen ovale in a cohort of young patients with cryptogenic ischemic stroke]
Marcus Tulius T Silva1, Roíza Rodrigues, João Tress
1Departamento de Neurologia, Universidade Federal Fluminense, Brazil. marcustulius@uol.com.br
Insights
Interatrial septal abnormalities, including patent foramen ovale (PFO) and atrial septal aneurysm (ASA), are prevalent in young patients with cryptogenic ischemic stroke (IS). Closure of these defects may prevent recurrent IS events.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Patent foramen ovale (PFO) and atrial septal aneurysm (ASA) are implicated in cryptogenic ischemic stroke (IS) in young adults.
- The association between PFO/ASA and IS risk, particularly when co-occurring, warrants further investigation.
Purpose of the Study:
- To determine the prevalence of PFO and ASA in young (<55 years) cryptogenic IS patients.
- To evaluate the outcomes following closure of interatrial septal abnormalities.
Main Methods:
- Transesophageal echocardiography (TEE) was used to diagnose interatrial septal abnormalities in 189 IS patients, with a focus on 32 younger than 55.
- Patients with cryptogenic IS and diagnosed abnormalities underwent percutaneous endovascular closure (PEC) or surgical closure.
- Follow-up included monthly assessments and antiplatelet therapy (AAS or Clopidogrel).
Main Results:
- Of 32 IS patients under 55, 29 had cryptogenic IS. Interatrial septal abnormalities were found in 41.3% (12/29).
- PFO was present in 5 patients, and PFO with ASA in 7.
- Ten patients underwent PEC, and 2 had surgical closure. No recurrent ischemic events were observed during a 28-month follow-up.
Conclusions:
- Interatrial septal abnormalities are common in young patients with cryptogenic IS.
- Closure of PFO and ASA appears to be a safe and potentially effective strategy for preventing recurrent ischemic events in this population.
Objective:
Although its role is a matter of debate, some studies described a higher prevalence of patent foramen ovale (PFO) and atrial septal aneurysm (ASA) in young stroke patients, with higher risk with PFO / ASA association (OR 4.96). The aim of this study was determine the prevalence of PFO and ASA in a cohort of cryptogenic ischemic stroke (IS) patients younger than 55 years and to follow-up after surgical or percutaneous endovascular closure (PEC).
Method:
In 21 months we identified all patients less than 55 years old with IS who were admitted to our hospital. Cryptogenic IS was considered if there is not an identifiably cause to cerebral ischemia. Transesophageal echocardiography (TEE) was performed in all patients. After interatrial septal abnormalities diagnosis, percutaneous device closure was offered to all. Patients were followed monthly and keeped with oral AAS or Clopidogrel.
Results:
We identified 189 patients with IS and 32 were less than 55 years old (16.9%). In 29 the IS was cryptogenic. TEE was performed in all patients and some form of interatrial septal abnormality was identified in 12 (12/29 - 41.3%); 5 had a PFO and in 7 there was PFO plus ASA. Ten patients were submitted to PEC and 2 were submitted to surgical closure. In mid-term follow-up (28 months) no ischemic events occurred and 2 patients related disappearance of migraine symptoms.
Conclusion:
Our small series description is in accordance with other studies and suggests a possible relation between interatrial septal abnormalities and IS in a cohort of young patient.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Transient Ischemic Attack l: Introduction

